Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation
Yanzhuo Ma1,2, Nancy Cheng2, Junping Sun2
1Department of Cardiology, Bethune International Peace Hospital, 398 Zhongshan Xilu, Shijiazhuang, 050082, Hebei, China.
Background:
Cardiac Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation plays a critical role in cardiomyocyte (CM) apoptosis and arrhythmia. Functional ATP-sensitive potassium (KATP) channels are essential for cardiac protection during ischemia. In cultured CMs, L5 low-density lipoprotein (LDL) induces apoptosis and QTc prolongation. L5 is a highly electronegative and atherogenic aberrant form of LDL, and its levels are significantly higher in patients with cardiovascular-related diseases. Here, the role of L5 in cardiac injury was studied by evaluating the effects of L5 on CaMKII activity and KATP channel physiology in CMs.
Methods:
Cultured neonatal rat CMs (NRCMs) were treated with a moderate concentration (ie, 7.5 μg/mL) of L5 or L1 (the least electronegative LDL subfraction). NRCMs were examined for apoptosis and viability, CaMKII activity, and the expression of phosphorylated CaMKIIδ and NOX2/gp91phox. The function of KATP and action potentials (APs) was analyzed by using the patch-clamp technique.
Results:
In NRCMs, L5 but not L1 significantly induced cell apoptosis and reduced cell viability. Furthermore, L5 decreased Kir6.2 expression by more than 50%. Patch-clamp analysis showed that L5 reduced the KATP current (IKATP) density induced by pinacidil, a KATP opener. The partial recovery of the inward potassium current during pinacidil washout was susceptible to subsequent inhibition by the IKATP blocker glibenclamide. Suppression of IKATP by L5 significantly prolonged the AP duration. L5 also significantly increased the activity of CaMKII, the phosphorylation of CaMKIIδ, and the expression of NOX2/gp91phox. L5-induced apoptosis was prevented by the addition of the CaMKII inhibitor KN93 and the reactive oxygen species scavenger Mn (III)TBAP.
Conclusions:
L5 but not L1 induces CM damage through the activation of the CaMKII pathway and increases arrhythmogenicity in CMs by modulating the AP duration. These results help to explain the harmful effects of L5 in cardiovascular-related disease.
Insights
Aberrant L5 low-density lipoprotein (LDL) induces cardiomyocyte apoptosis and arrhythmia by activating CaMKII and impairing KATP channels. This finding clarifies L5
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cellular Physiology
Background:
- Cardiac Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation is crucial in cardiomyocyte (CM) apoptosis and arrhythmia.
- Functional ATP-sensitive potassium (KATP) channels are vital for cardiac protection during ischemia.
- Aberrant L5 low-density lipoprotein (LDL), a pro-atherogenic form, is elevated in cardiovascular diseases and linked to CM apoptosis and QTc prolongation.
Purpose of the Study:
- To investigate the role of L5 in cardiac injury.
- To evaluate the effects of L5 on CaMKII activity in CMs.
- To assess L5's impact on KATP channel physiology in CMs.
Main Methods:
- Neonatal rat CMs (NRCMs) were treated with L5 or L1 (control LDL subfraction).
- Apoptosis, viability, CaMKII activity, and protein expression (phosphorylated CaMKIIδ, NOX2/gp91phox) were assessed.
- KATP channel function and action potentials (APs) were analyzed using patch-clamp techniques.
Main Results:
- L5 significantly induced CM apoptosis and reduced viability, unlike L1.
- L5 decreased Kir6.2 expression and KATP current (IKATP) density, prolonging AP duration.
- L5 increased CaMKII activity, CaMKIIδ phosphorylation, and NOX2/gp91phox expression.
- L5-induced apoptosis was mitigated by CaMKII inhibition and reactive oxygen species scavenging.
Conclusions:
- L5, but not L1, damages CMs by activating the CaMKII pathway.
- L5 increases cardiac arrhythmogenicity by modulating AP duration.
- These findings elucidate the detrimental effects of L5 in cardiovascular disease.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Coronary Artery Disease II: Pathophysiology
Antihypertensive Drugs: Action of Calcium Channel Blockers
Atherosclerosis I: Introduction
cAMP-dependent Protein Kinase Pathways


